Skip to main content
. 2022 Apr 11;35(2):e14376. doi: 10.1111/nmo.14376

TABLE 3.

Symptoms and GMA before and after the nutrient bar test meal in patients with gastroparesis and functional dyspepsia

Gastroparesis (n = 283) Functional dyspepsia (n = 112) p‐value c
Mean (SD) Mean (SD)
Nutrient meal test
Water taken with smart bar—ml 53 (45) 60 (60) 0.27 e
Smart bar—% consumed 83 (25) 90 (20) 0.006 e
Test length—min 8.5 (2.4) 8.5 (2.2) 0.38
Symptoms (VAS 0–100)
Fullness
Baseline 28 (30) 30 (32) 0.74
Change a 30 (31) 33 (30) 0.33
Hunger
Baseline 34 (30) 33 (31) 0.93
Change a −18 (27) d −20 (26) d 0.56
Nausea
Baseline 29 (31) 28 (31) 0.78
Change a 2 (19) 6 (22) 0.55
Bloating
Baseline 29 (31) 28 (31) 0.67
Change a 9 (20) 9 (21) 0.66
Abdominal discomfort
Baseline 26 (30) 26 (30) 0.88
Change a 4 (19) 5 (17) 0.11
GMA (distribution of average—%)
Bradygastria (1–2.4 cpm)
Baseline 51 (20) 50 (20) 0.66
Change b −4 (18) −3 (18) 0.50
Normogastria (2.5–3.7 cpm)
Baseline 19 (13) 21 (14) 0.29
Change b 4 (13) 4 (15) 0.92
Tachygastria (3.8–10 cpm)
Baseline 23 (12) 22 (11) 0.53
Change b 2 (11) 0 (10) 0.22
Duodenal (>10–15 cpm)
Baseline 7 (8) 7 (8) 0.98
Change b −1 (7) −1 (7) 0.12

Abbreviations: GMA, gastric myoelectrical activity; GP, gastroparesis.

a

Mean of 6 values taken at 0, 15, 30, 45, 60, and 90 min after start of test—baseline.

b

Mean of 5 values taken at 15, 30, 45, 60, and 90 min after start of test—baseline.

c

p‐value derived from robust regression of outcome on GP type for baseline and robust regression of change in outcome on GP type and baseline value of outcome.

d

p‐value based on Kruskal–Wallis test due to non‐convergence using robust regression.

e

p‐value based on the t test.

e

Bold values indicates the significant of 0.006 value.